Dr. Darren Tyson is an expert in cancer systems biology whose work integrates cutting-edge experiments with computational modeling to uncover how cancer cells adapt to therapy. His research has advanced understanding of the molecular pathways that drive drug response, resistance, and phenotypic plasticity, and he brings deep experience in evaluating drug combinations and therapeutic synergy.

Dr. Tyson earned his Ph.D. from Saint Louis University, completed postdoctoral training at the University of California, Irvine, and spent over 15 years at Vanderbilt University as a site of the NCI Consortium for Cancer Systems Biology. He is currently an Associate Research Professor at Duke University School of Medicine and a member of the Duke Cancer Institute.